Differential expression of plasma miRNAs in patients with unprovoked venous thromboembolism and healthy control individuals

Thrombosis Research

Volumn 136, Issue 3, 2015, Pages 566-572

  Starikova, Irina ^a,b   Jamaly, Simin ^a   Sorrentino, Antonio ^c   Blondal, Thorarinn ^c   Latysheva, Nadezhda ^a   Sovershaev, Mikhail ^b   Hansen, John Bjarne ^a,b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^c Exiqon A/S   (Denmark)

Author keywords

biomarker; extracellular vesicles; microRNA; plasma; venous thromboembolism

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 103A 3P; MICRORNA 10B 5P; MICRORNA 191 5P; MICRORNA 199B 3P; MICRORNA 301A 3P; MICRORNA 320A; MICRORNA 320B; MICRORNA 423 5P; MICRORNA 424 5P; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EXOSOME; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; MALE; MEDICAL HISTORY; MICRORNA BLOOD LEVEL; PILOT STUDY; PLASMA; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RNA EXTRACTION; SEX RATIO; UPREGULATION; VENOUS THROMBOEMBOLISM; BLOOD; GENETICS; MIDDLE AGED; REFERENCE VALUE; REGISTER; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

BIOMARKERS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MICRORNAS; MIDDLE AGED; REFERENCE VALUES; REGISTRIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VENOUS THROMBOEMBOLISM;

EID: 84940439829     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2015.07.005     Document Type: Article

References (33)

1. N. Mackman New insights into the mechanisms of venous thrombosis J. Clin. Invest. 122 7 2012 2331 2336
2. T.P. Baglin, K. White, and A. Charles Fatal pulmonary embolism in hospitalised medical patients J. Clin. Pathol. 50 7 1997 609 610
3. D.N. Mohr, M.D. Silverstein, J.A. Heit, T.M. Petterson, W.M. O'Fallon, and L.J. Melton The venous stasis syndrome after deep venous thrombosis or pulmonary embolism: a population-based study Mayo Clinic proceedings Mayo Clinic 75(12) 2000 1249 1256
4. J.A. Heit, C.E. Kobbervig, A.H. James, T.M. Petterson, K.R. Bailey, and L.J. Melton 3rd. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study Ann. Intern. Med. 143 10 2005 697 706
5. D.P. Bartel MicroRNAs: target recognition and regulatory functions Cell 136 2 2009 215 233
6. N. Bushati, and S.M. Cohen microRNA functions Annu. Rev. Cell Dev. Biol. 23 2007 175 205
7. M.P. Hunter, N. Ismail, X. Zhang, B.D. Aguda, E.J. Lee, L. Yu, and et al. Detection of microRNA expression in human peripheral blood microvesicles PLoS One 3 11 2008 e3694
8. J.D. Arroyo, J.R. Chevillet, E.M. Kroh, I.K. Ruf, C.C. Pritchard, D.F. Gibson, and et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma Proc. Natl. Acad. Sci. U. S. A. 108 12 2011 5003 5008
9. K.C. Vickers, B.T. Palmisano, B.M. Shoucri, R.D. Shamburek, and A.T. Remaley MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins Nat. Cell Biol. 13 4 2011 423 433
10. S. Fichtlscherer, A.M. Zeiher, and S. Dimmeler Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? Arterioscler. Thromb. Vasc. Biol. 31 11 2011 2383 2390
11. Y. D'Alessandra, P. Devanna, F. Limana, S. Straino, A. Di Carlo, P.G. Brambilla, and et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction Eur. Heart J. 31 22 2010 2765 2773
12. C. Voellenkle, J. van Rooij, C. Cappuzzello, S. Greco, D. Arcelli, L. Di Vito, and et al. MicroRNA signatures in peripheral blood mononuclear cells of chronic heart failure patients Physiol. Genomics 42 3 2010 420 426
13. P.S. Mitchell, R.K. Parkin, E.M. Kroh, B.R. Fritz, S.K. Wyman, E.L. Pogosova-Agadjanyan, and et al. Circulating microRNAs as stable blood-based markers for cancer detection Proc. Natl. Acad. Sci. U. S. A. 105 30 2008 10513 10518
14. S.K. Braekkan, E.M. Hald, E.B. Mathiesen, I. Njolstad, T. Wilsgaard, F.R. Rosendaal, and et al. Competing risk of atherosclerotic risk factors for arterial and venous thrombosis in a general population: the Tromso study Arterioscler. Thromb. Vasc. Biol. 32 2 2012 487 491
15. B.K. Jacobsen, A.E. Eggen, E.B. Mathiesen, T. Wilsgaard, and I. Njolstad Cohort profile: the Tromso Study Int. J. Epidemiol. 41 4 2012 961 967
16. R.M. Bertina, B.P. Koeleman, T. Koster, F.R. Rosendaal, R.J. Dirven, H. de Ronde, and et al. Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 369 6475 1994 64 67
17. S.R. Poort, F.R. Rosendaal, P.H. Reitsma, and R.M. Bertina A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis Blood 88 10 1996 3698 3703
18. B.P. Lewis, C.B. Burge, and D.P. Bartel Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets Cell 120 1 2005 15 20
19. A. Krek, D. Grun, M.N. Poy, R. Wolf, L. Rosenberg, E.J. Epstein, and et al. Combinatorial microRNA target predictions Nat. Genet. 37 5 2005 495 500
20. A. Kozomara, and S. Griffiths-Jones miRBase: integrating microRNA annotation and deep-sequencing data Nucleic Acids Res. 39 Database issue 2011 D152 D157
21. T. Blondal, S. Jensby Nielsen, A. Baker, D. Andreasen, P. Mouritzen, M. Wrang Teilum, and et al. Assessing sample and miRNA profile quality in serum and plasma or other biofluids Methods 59 1 2013 S1 S6
22. F.R. Rosendaal Venous thrombosis: a multicausal disease Lancet 353 9159 1999 1167 1173
23. M. Mayr, A. Zampetaki, P. Willeit, J. Willeit, and S. Kiechl MicroRNAs within the continuum of postgenomics biomarker discovery Arterioscler. Thromb. Vasc. Biol. 33 2 2013 206 214
24. E.E. Creemers, A.J. Tijsen, and Y.M. Pinto Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ. Res. 110 3 2012 483 495
25. J. Xiao, Z.C. Jing, P.T. Ellinor, D. Liang, H. Zhang, Y. Liu, and et al. MicroRNA-134 as a potential plasma biomarker for the diagnosis of acute pulmonary embolism J. Transl. Med. 9 2011 159
26. J. Qin, H. Liang, D. Shi, J. Dai, Z. Xu, D. Chen, and et al. A panel of microRNAs as a new biomarkers for the detection of deep vein thrombosis J. Thromb. Thrombolysis 39 2 2015 215 221
27. L. Issman, B. Brenner, Y. Talmon, and A. Aharon Cryogenic transmission electron microscopy nanostructural study of shed microparticles PLoS One 8 12 2013 e83680
28. O. Gidlof, M. van der Brug, J. Ohman, P. Gilje, B. Olde, C. Wahlestedt, and et al. Platelets activated during myocardial infarction release functional miRNA, which can be taken up by endothelial cells and regulate ICAM1 expression Blood. 121 19 2013 3908 3917 (S1-26)
29. S.K. Braekkan, E.B. Mathiesen, I. Njolstad, T. Wilsgaard, J. Stormer, and J.B. Hansen Mean platelet volume is a risk factor for venous thromboembolism: the Tromso Study, Tromso, Norway J. Thromb. Haemost. 8 1 2010 157 162
30. T.A. Brighton, J.W. Eikelboom, K. Mann, R. Mister, A. Gallus, P. Ockelford, and et al. Low-dose aspirin for preventing recurrent venous thromboembolism N. Engl. J. Med. 367 21 2012 1979 1987
31. C. Becattini, G. Agnelli, A. Schenone, S. Eichinger, E. Bucherini, M. Silingardi, and et al. Aspirin for preventing the recurrence of venous thromboembolism N. Engl. J. Med. 366 21 2012 1959 1967
32. M.B. Kirschner, J.J. Edelman, S.C. Kao, M.P. Vallely, N. van Zandwijk, and G. Reid The Impact of Hemolysis on Cell-Free microRNA Biomarkers Front. Genet. 4 2013 94
33. L. Pigati, S.C. Yaddanapudi, R. Iyengar, D.J. Kim, S.A. Hearn, D. Danforth, and et al. Selective release of microRNA species from normal and malignant mammary epithelial cells PLoS One 5 10 2010 e13515